PLK2 and neoplasm: This research found that binding of PLK2 to the tumor suppressor Fbxw7 resulted in increased degradation of Fbxw7 and stabilization of Cyclin E; this suggested that PLK2 may act as a tumor supportive factor, may serve as a prognostic and diagnostic target and furthermore as a therapeutic target [116].